Please check your internet connection and try again.
# Tab%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520voihep
## Overview
Tab%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520voihep is a nucleoside analog used in the treatment of chronic hepatitis B virus (HBV) infection. It works by inhibiting viral DNA polymerase.
## Primary Indications
* Chronic Hepatitis B virus (HBV) infection in adults and pediatric patients.
## Adult Dosing
The recommended dose of Tab%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520voihep is typically 100 mg orally once daily.
## Pediatric Dosing
For pediatric patients aged 12 years and older and weighing at least 35 kg, the dose is 100 mg orally once daily. Dosing for younger or lighter pediatric patients should be based on local protocol or specific product labeling.
## Dose Adjustments
* **Renal Impairment:** Dose adjustment is required for patients with impaired renal function. Specific dosing guidelines vary based on the calculated creatinine clearance.
* If CrCl is 30 to <50 mL/min: 100 mg every 2 days.
* If CrCl is 10 to <30 mL/min: 100 mg every 3 days.
* If CrCl is <10 mL/min or undergoing hemodialysis/continuous ambulatory peritoneal dialysis: 100 mg every 7 days or after each dialysis session.
## Contraindications
* Hypersensitivity to Tab%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520voihep or any of its excipients.
## Adverse Effects
Common adverse effects include headache, nausea, vomiting, diarrhea, fatigue, dizziness, and insomnia. Serious adverse effects may include lactic acidosis, severe hepatomegaly with steatosis, and exacerbations of hepatitis B upon discontinuation.
## Key Drug Interactions
* **Other Nephrotoxic Agents:** Concomitant use with other drugs that can cause renal impairment may increase the risk of renal side effects.
* **Drugs Excreted by Renal Tubules:** caution is advised with co-administration of drugs that are actively secreted by the renal tubules, as competition for excretion may occur.
## Monitoring
* Liver function tests (ALT, AST, bilirubin) regularly.
* Renal function (serum creatinine, GFR) should be assessed at baseline and periodically during treatment.
* Hepatitis B viral DNA load should be monitored to assess treatment efficacy.
* Monitor for signs and symptoms of lactic acidosis and severe hepatomegaly.
## Clinical Pearls
* Treatment duration should be individualized. Discontinuation of Tab%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520voihep can lead to a sudden and severe exacerbation of hepatitis B, which can be fatal. Do not discontinue treatment without close medical supervision.
* Patients with renal impairment require careful dose adjustment and monitoring.
* Consider the risk of lactic acidosis and severe hepatomegaly, especially in patients with risk factors such as obesity or prolonged treatment.
---
*This information is intended for healthcare professionals. Always verify current prescribing information and consult with a qualified healthcare provider for any medical advice or treatment decisions.*
